Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica flag Jamaica · Delayed Price · Currency is JMD
3.000
+0.050 (1.69%)
At close: Feb 27, 2026
-9.91%
Market Cap 4.00B
Revenue (ttm) 1.13B
Net Income (ttm) 181.29M
Shares Out 1.33B
EPS (ttm) 0.14
PE Ratio 22.05
Forward PE n/a
Dividend 0.14 (4.58%)
Ex-Dividend Date Mar 31, 2025
Volume 168,628
Average Volume 108,404
Open n/a
Previous Close 2.950
Day's Range 2.900 - 3.000
52-Week Range 2.330 - 3.770
Beta 0.05
RSI 55.74
Earnings Date Mar 13, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 64
Stock Exchange Jamaica Stock Exchange
Ticker Symbol INDIES
Full Company Profile

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.

Financial Statements

News

There is no news available yet.